All currently US Food and Drug Administration (FDA)-approved insulin still have a narrow therapeutic window: insulin overdoses lead to hypoglycemia and underdoses result in hyperglycemia (Peyrot et al., 2012). Here, INS is linked to Hyperglycemia.